Cargando…

Time Trends in the Burden of Hospitalizations with Invasive Aspergillosis in the United States, 2004–2013

BACKGROUND: Invasive aspergillosis (IA) remains a burdensome illness and is associated with substantial mortality. With increasing use of aggressive chemotherapy and immunomodulatory treatments, the prevalence of IA is likely to have grown. However, little is known about the current US burden of IA-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilberberg, Marya D, Harrington, Rachel, Spalding, James, Shorr, Andrew F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631595/ http://dx.doi.org/10.1093/ofid/ofx163.006

Ejemplares similares

Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004–2013
por: Zilberberg, Marya D., et al.
Publicado: (2019)

Epidemiology and Outcomes of Hospitalizations with Invasive Aspergillosis in the United States, 2010–2013
por: Zilberberg, Marya D, et al.
Publicado: (2017)

1455. Epidemiology, Empiric Treatment, and Outcomes Among Hospitalized Patients With Complicated Urinary Tract Infections in the United States, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

2259. Predictors of Empiric Carbapenem Therapy in Complicated Intra-Abdominal Infections in the United States, 2013–2017: A Retrospective Cohort Study
por: Zilberberg, Marya, et al.
Publicado: (2019)

1461. Antimicrobial Susceptibility Patterns of Common Complicated Urinary Tract Infection Pathogens in US Hospitals, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States
por: Kaye, Keith S, et al.
Publicado: (2019)

Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning
por: Zilberberg, Marya D, et al.
Publicado: (2008)

2817. Outcomes of Timely vs. Delayed Meropenem/Vaborbactam Treatment of Infections with CRE among Adults Hospitalized in the US, 2019-2021
por: Zilberberg, Marya D, et al.
Publicado: (2023)

Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019
por: Zilberberg, Marya, et al.
Publicado: (2021)

Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018
por: Zilberberg, Marya D, et al.
Publicado: (2022)

1430. Descriptive Epidemiology of Emergency Department Visits with cUTI in the US, 2012-2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016–2018
por: Zilberberg, Marya D., et al.
Publicado: (2022)

2816. Comparative Effectiveness of Meropenem/Vaborbactam vs. Ceftazidime/Avibactam among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021
por: Zilberberg, Marya D, et al.
Publicado: (2023)

Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013–2018: a retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2021)

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2021)

718 Predictors of Hospital Mortality Among Septic ICU Patients With Acinetobacter spp. Bacteremia: A Cohort Study
por: Shorr, Andrew F., et al.
Publicado: (2014)

1658 C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients
por: Zilberberg, Marya D., et al.
Publicado: (2014)

Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Gram-negative resistance and need for ICU among urinary tract infections in the United States
por: Zilberberg, M, et al.
Publicado: (2013)

Trends in the Burden and Seasonality of Rotavirus in the United States, 2000–2016
por: Aliabadi, Negar, et al.
Publicado: (2017)

Assessment of Reporting Bias for Clostridium difficile Hospitalizations, United States
por: Zilberberg, Marya D.
Publicado: (2008)

1461. Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
por: Matanock, Almea, et al.
Publicado: (2018)

Examining the Burden of Potentially Avoidable Heart Failure Hospitalizations
por: Zilberberg, Marya D, et al.
Publicado: (2023)

Tuberculosis Caused by Mycobacterium africanum, United States, 2004–2013
por: Sharma, Aditya, et al.
Publicado: (2016)

Embryo cryopreservation and utilization in the United States from 2004–2013
por: Christianson, Mindy S., et al.
Publicado: (2020)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2007)

Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2012)

Statistics on steroids: How recognizing competing risks gets us closer to the truth about COVID-19-associated VAP
por: Shorr, Andrew F., et al.
Publicado: (2022)

Invasive Cancer Incidence, 2004–2013, and Deaths, 2006–2015, in Nonmetropolitan and Metropolitan Counties — United States
por: Henley, S. Jane, et al.
Publicado: (2017)

Trends in Tuberculosis — United States, 2013
por: Alami, Negar Niki, et al.
Publicado: (2014)

610. Voriconazole versus isavuconazole in patients with invasive aspergillosis: a retrospective study in a medically insured population across the United States
por: Chan, Sophea, et al.
Publicado: (2023)

868. Investigations of Healthcare-Associated Elizabethkingia Infections – United States, 2013-2019
por: Crist, Matthew B, et al.
Publicado: (2020)

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2009)

354. Evidence of Aspergillosis Among Patients With Influenza-Associated Hospitalizations—United States, 2005–2017
por: Toda, Mitsuru, et al.
Publicado: (2018)

Time trends and changes in the distribution of malaria cases in the Brazilian Amazon Region, 2004-2013
por: Lima, Isac da SF, et al.
Publicado: (2016)

Obesity trends by industry of employment in the United States, 2004 to 2011
por: Jackson, Chandra L., et al.
Publicado: (2016)

Trends in intracranial meningioma incidence in the United States, 2004‐2015
por: Lin, Dong‐Dong, et al.
Publicado: (2019)

384. Invasive aspergillosis in COVID-19 patients in an intensive care unit in Mexico City
por: Velez-Pintado, Mariana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s9ka033tq673vmar4a216o336r